EcoDrugPlus

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSMZEG00005010676
Gene Symbol: AVPR1A
1 Cross references
169 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSMZEG00005021618
Gene Symbol: AVPR1A
3 Cross references
195 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSMZEG00005010596
Gene Symbol: AVPR1A
3 Cross references
169 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSMZEG00005027237
Gene Symbol: AVPR2
3 Cross references
178 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSMZEG00005026693
Gene Symbol: AVPR2
3 Cross references
148 Possible Orthologues:

Aromatase

Ensembl ID : ENSMZEG00005007207
Gene Symbol: LOC101468629
3 Cross references
249 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 1

Ensembl ID : ENSMZEG00005012206
Gene Symbol: LOC101481488
3 Cross references
190 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 1

Ensembl ID : ENSMZEG00005023699
Gene Symbol: LOC101472037
2 Cross references
191 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 2

Ensembl ID : ENSMZEG00005014806
Gene Symbol: LOC101476270
2 Cross references
185 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSMZEG00005006183
Gene Symbol: AURKA
3 Cross references
232 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSMZEG00005009240
Gene Symbol: LOC101477914
3 Cross references
205 Possible Orthologues:

Bcl-2-Like Protein 1

Ensembl ID : ENSMZEG00005010193
Gene Symbol: LOC101485344
2 Cross references
219 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).